SCHEMBL427376

SCHEMBL427376

CN(C(=O)n1nnc2ccccc21)[C@H]1CC[C@H](OCc2ccccc2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 5/20 0.46
MGLL Q99685 4/20 0.46
TRPV1 Q8NER1 1/20 0.42
HTT P42858 3/20 0.41
NPSR1 Q6W5P4 3/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 4/20 0.41
MGAM O43451 3/20 0.41
AMY1A P0DUB6 3/20 0.41
SI P14410 3/20 0.41
MGAM2 Q2M2H8 3/20 0.41
F12 P00748 3/20 0.41
F2 P00734 2/20 0.41
HPGD P15428 1/20 0.41
SLC9A1 P19634 1/20 0.41
MIF P14174 1/20 0.41
ASAH1 Q13510 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL427899 0.81 KMT2A (0.49) FAAHMGLLTRPV1HTTNPSR1
SCHEMBL427878 0.81 FAAH (0.60) FAAHMGLLHTTALDH1A1OPRM1
SCHEMBL424622 0.81 KMT2A (0.51) FAAHMGLLTRPV1HTTNPSR1
SCHEMBL424342 0.80 TRPV1 (0.53) FAAHMGLLTRPV1HTTNPSR1
SCHEMBL425704 0.78 FAAH (0.70) FAAHMGLL
SCHEMBL427408 0.78 KMT2A (0.48) FAAHMGLLHTTNPSR1KMT2A
SCHEMBL427990 0.73 FAAH (0.52) FAAHMGLLTRPV1EPHX2OPRM1
SCHEMBL427381 0.73 KMT2A (0.45) FAAHMGLLHTTNPSR1KMT2A
SCHEMBL424469 0.72 KMT2A (0.43) FAAHMGLLTRPV1HTTNPSR1
SCHEMBL425437 0.72 GAA (0.52) FAAHMGLLHTTNPSR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-9353082-B2 Pharmaceutical compounds BIAL—PORTELA & CA, S.A. (PT) 2016-05-31 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2012-03-15 US disclosed
WO-2010074588-A2 PHARMACEUTICAL COMPOUNDS BIAL - PORTELA & Cª, S.A. (PT) 2010-07-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120065191-A1 PHARMACEUTICAL COMPOUNDS FAAH, FAAH2, ASAH1 FAAH 1/4885MGLL 11/4885TRPV1 165/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.